ErbB2, but not ErbB1, reinitiates proliferation and induces luminal repopulation in epithelial acini
- PMID: 11533657
- PMCID: PMC2952547
- DOI: 10.1038/ncb0901-785
ErbB2, but not ErbB1, reinitiates proliferation and induces luminal repopulation in epithelial acini
Abstract
Both ErbB1 and ErbB2 are overexpressed or amplified in breast tumours. To examine the effects of activating ErbB receptors in a context that mimics polarized epithelial cells in vivo, we activated ErbB1 and ErbB2 homodimers in preformed, growth-arrested mammary acini cultured in three-dimensional basement membrane gels. Activation of ErbB2, but not that of ErbB1, led to a reinitiation of cell proliferation and altered the properties of mammary acinar structures. These altered structures share several properties with early-stage tumours, including a loss of proliferative suppression, an absence of lumen, retention of the basement membrane and a lack of invasive properties. ErbB2 activation also disrupted tight junctions and the cell polarity of polarized epithelia, whereas ErbB1 activation did not have any effect. Our results indicate that ErbB receptors differ in their ability to induce early stages of mammary carcinogenesis in vitro and this three-dimensional model system can reveal biological activities of oncogenes that cannot be examined in vitro in standard transformation assays.
Figures






Similar articles
-
Controlled activation of ErbB1/ErbB2 heterodimers promote invasion of three-dimensional organized epithelia in an ErbB1-dependent manner: implications for progression of ErbB2-overexpressing tumors.Cancer Res. 2006 May 15;66(10):5201-8. doi: 10.1158/0008-5472.CAN-05-4081. Cancer Res. 2006. PMID: 16707444
-
Controlled dimerization of ErbB receptors provides evidence for differential signaling by homo- and heterodimers.Mol Cell Biol. 1999 Oct;19(10):6845-57. doi: 10.1128/MCB.19.10.6845. Mol Cell Biol. 1999. PMID: 10490623 Free PMC article.
-
ERBB1 and ERBB2 have distinct functions in tumor cell invasion and intravasation.Clin Cancer Res. 2009 Jun 1;15(11):3733-9. doi: 10.1158/1078-0432.CCR-08-2163. Epub 2009 May 19. Clin Cancer Res. 2009. PMID: 19458057 Free PMC article.
-
Sequestration and segregation of receptor kinases in epithelial cells: implications for ErbB2 oncogenesis.Sci STKE. 2007 Apr 10;2007(381):re3. doi: 10.1126/stke.3812007re3. Sci STKE. 2007. PMID: 17426346 Review.
-
The relative role of ErbB1-4 receptor tyrosine kinases in radiation signal transduction responses of human carcinoma cells.Oncogene. 2001 Mar 15;20(11):1388-97. doi: 10.1038/sj.onc.1204255. Oncogene. 2001. PMID: 11313882 Review.
Cited by
-
Ezrin and BCAR1/p130Cas mediate breast cancer growth as 3-D spheroids.Clin Exp Metastasis. 2012 Aug;29(6):527-40. doi: 10.1007/s10585-012-9468-2. Epub 2012 Apr 4. Clin Exp Metastasis. 2012. PMID: 22476538
-
ErbB2, FoxM1 and 14-3-3ζ prime breast cancer cells for invasion in response to ionizing radiation.Oncogene. 2014 Jan 30;33(5):589-98. doi: 10.1038/onc.2012.629. Epub 2013 Jan 14. Oncogene. 2014. PMID: 23318431 Free PMC article.
-
HER2-CD3-Fc Bispecific Antibody-Encoding mRNA Delivered by Lipid Nanoparticles Suppresses HER2-Positive Tumor Growth.Vaccines (Basel). 2024 Jul 21;12(7):808. doi: 10.3390/vaccines12070808. Vaccines (Basel). 2024. PMID: 39066446 Free PMC article.
-
Inducible dimerization of FGFR1: development of a mouse model to analyze progressive transformation of the mammary gland.J Cell Biol. 2002 May 13;157(4):703-14. doi: 10.1083/jcb.200107119. Epub 2002 May 13. J Cell Biol. 2002. PMID: 12011115 Free PMC article.
-
HER-2 overexpression differentially alters transforming growth factor-beta responses in luminal versus mesenchymal human breast cancer cells.Breast Cancer Res. 2005;7(6):R1058-79. doi: 10.1186/bcr1343. Epub 2005 Nov 8. Breast Cancer Res. 2005. PMID: 16457687 Free PMC article.
References
-
- Petersen OW, Ronnov-Jessen L, Howlett AR, Bissell MJ. Interaction with basement membrane serves to rapidly distinguish growth and differentiation pattern of normal and malignant human breast epithelial cells. Proc Natl Acad Sci USA. 1992;89:9064–9068. (Erratum, Proc. Natl Acad. Sci. USA90, 2556 (1993).) - PMC - PubMed
-
- Harris J, Lippman M, Morrow M, Osborne C. Diseases of the Breast. Lippincott Williams and Wilkins; Philadelphia: 1999.
-
- Riese DJ, 2nd, Stern DF. Specificity within the EGF family/ErbB receptor family signaling network. BioEssays. 1998;20:41–48. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous